Real-time availability status for Ozempic, Wegovy, Mounjaro, Zepbound and other GLP-1 medications
Last checked: February 12, 2026
Ozempic, Wegovy, Rybelsus
Mounjaro, Zepbound
Saxenda, Victoza
Brand names: Ozempic, Wegovy, Rybelsus
No current shortages reported for semaglutide products.
Brand names: Mounjaro, Zepbound
No current shortages reported for tirzepatide products.
Brand names: Saxenda, Victoza
9 shortage record(s) found in FDA database:
Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03)
Hikma Pharmaceuticals USA, Inc.
Updated: 01/22/2026
Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)
Novo Nordisk, Inc.
Updated: 02/01/2026
Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)
Meitheal Pharmaceuticals, Inc.
Updated: 08/19/2025
Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84)
Meitheal Pharmaceuticals, Inc.
Updated: 08/19/2025
Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)
Novo Nordisk, Inc.
Updated: 02/01/2026
Subscribe to receive updates when GLP-1 medication availability changes
Data sourced from the FDA Drug Shortage Database. Updated weekly via the openFDA API.